ALS Full Year results

• Revenue of $3.32 billion, up 10.7%
• Underlying NPAT increased by 25.8% to $381.2 million
• Final dividend of 23.1 cents per share, 10.1% higher than FY25

ALS Limited (ASX: ALQ) announced its FY26 results, showcasing a 10.7% increase in revenue to $3.32 billion and a 25.8% rise in underlying NPAT to $381.2 million. The company attributed the growth to strong organic growth in Commodities, particularly in Minerals, and favourable FX impacts. Underlying EBIT increased by 19.3% to $599.0 million, with the margin improving by 129 basis points to 18.0%. The company also announced a final dividend of 23.1 cents per share, a 10.1% increase from the previous year. The balance sheet remains strong with a leverage ratio of 1.5x, well below the targeted range of 1.7 to 2.3x. Looking ahead, ALS targets mid to high single-digit organic revenue growth for FY27 with margin expansion similar to FY26.

FY27: Targeting mid to high single-digit organic revenue growth and margin expansion

ALS expects to maintain strong performance in FY27, with Minerals anticipating 13-15% organic revenue growth and Life Sciences targeting improved mid-single digit organic revenue growth.